SEARCH BY

Issuer directory Issuer directory
KEYWORDS
COMPANIES / ISIN
TYPE OF INFORMATION
INDUSTRY

Start search  ADVANCED SEARCH

COMPARTMENTS / INDICES

France
America
Asia
Oceania
Africa
Europe

MSI NEWS

FEEDS

My RSS My Google Microsoft Live My Yahoo

COMPANY SEARCH RESULT

NOVARTIS: Click to view the issuer\'s details

Last update : 28/01/2011  >View issuer details

2019.09.03 | 07:15 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Sandoz announces global deal to commercialize proposed biosimilar natalizumab, a key multiple sclerosis medicine - HTML (w)

2019.09.01 | 14:30 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Novartis PARAGON-HF trial suggests Entresto® benefit in HFpEF patients but narrowly misses primary endpoint - HTML (w)

2019.08.09 | 21:46 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Sandoz will appeal District Court of New Jersey ruling in biosimilar Erelzi® (etanercept-szzs) US patent case - HTML (w)

2019.07.01 | 17:30 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Novartis successfully completes acquisition of Xiidra®, bolstering ophthalmic portfolio - HTML (w)

2019.06.12 | 07:15 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Novartis Cosentyx® first to show efficacy in all key manifestations of psoriatic arthritis - HTML (w)

Pages : 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - 10 / Doc nb : 1236